Genmab Publishes 2024 Annual Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- US stock futures up as chip shares recover, oil prices decline
- Oil falls after OPEC+ agrees to raise output targets
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
Truist Securities Reiterates Buy Rating on Genmab A/S (GMAB)
February 13, 2025 7:17 AM ESTTruist Securities analyst Asthika Goonewardene reiterated a Buy rating and $50.00 price target on Genmab A/S (NASDAQ: GMAB).
The analyst comments "We believe investors are anxious to own GMAB ahead of J&J's (JNJ, Not Rated) decision to opt-in on GEN3014, and... More
